426. Use of Real Time IP-10 Measurements to Identify and Monitor the Dysregulated Immune Response in COVID-19 Patients

BACKGROUND: It is estimated that up to 10% of SARS-CoV-2 patients progress from early and pulmonary stages to the most severe stage of illness, which manifests as an extra-pulmonary systemic hyperinflammatory syndrome. Interferon gamma-induced protein 10 (IP-10) is an inflammatory marker that plays...

Descripción completa

Detalles Bibliográficos
Autores principales: Lev, Shaul, Gottesman, Tamar, Levin, Gal Shachaf, Ber, Tahel Ilan, Angel, Alon, Kellerman, Lior, Barash, Eran, Navon, Roy, Simon, Einav, Avni, Noa, Hainrichson, Mary, Gottlieb, Tanya, Oved, Kfir, Eden, Eran, Tadmor, Boaz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Poster Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776517/
http://dx.doi.org/10.1093/ofid/ofaa439.620

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776517/
http://dx.doi.org/10.1093/ofid/ofaa439.620

Ejemplares similares